Downstream Bioprocessing 2021

The route to downstream process and analytical innovation for efficient AAV vector manufacture

Cell & Gene Therapy Insights 2021; 7(11), 1527–1532


Published: 6 December 2021

Matthew Roach leads the AAV Process Development group at Precision BioSciences, which is focused on designing and implementing new strategies for the production and purification of adeno-associated virus. Matt completed his Bachelor’s degree in Biological Sciences at North Carolina State University and his Master’s degree in Microbiology and Cell Science at the University of Florida. Prior to Precision, Matt spent time at Pfizer working on the purification of AAV and the Biomanufacturing Training and Education Center training industry professionals on downstream bioprocessing operations.